EE9500059A - Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena - Google Patents
Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitenaInfo
- Publication number
- EE9500059A EE9500059A EE9500059A EE9500059A EE9500059A EE 9500059 A EE9500059 A EE 9500059A EE 9500059 A EE9500059 A EE 9500059A EE 9500059 A EE9500059 A EE 9500059A EE 9500059 A EE9500059 A EE 9500059A
- Authority
- EE
- Estonia
- Prior art keywords
- medicaments
- phenyl
- substituted
- acid derivatives
- aminonicotinic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4430638A DE4430638A1 (de) | 1994-08-29 | 1994-08-29 | Verwendung von substituierten 4-Phenyl-6-amino-nicotinsäurederivaten als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9500059A true EE9500059A (et) | 1996-04-15 |
Family
ID=6526833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9500059A EE9500059A (et) | 1994-08-29 | 1995-08-28 | Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5670525A (et) |
| EP (1) | EP0705820A1 (et) |
| JP (1) | JPH0867670A (et) |
| KR (1) | KR960007565A (et) |
| CN (1) | CN1127114A (et) |
| AU (1) | AU697552B2 (et) |
| CA (1) | CA2156961A1 (et) |
| CZ (1) | CZ219895A3 (et) |
| DE (1) | DE4430638A1 (et) |
| EE (1) | EE9500059A (et) |
| FI (1) | FI954007A (et) |
| HU (1) | HUT74618A (et) |
| IL (1) | IL115072A (et) |
| NO (1) | NO308287B1 (et) |
| NZ (1) | NZ272851A (et) |
| PL (1) | PL310145A1 (et) |
| RU (1) | RU2154635C2 (et) |
| SK (1) | SK106595A3 (et) |
| TW (1) | TW419464B (et) |
| ZA (1) | ZA957187B (et) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001523002A (ja) * | 1997-11-10 | 2001-11-20 | ブリストル−マイヤーズ スクイブ カンパニー | アルツハイマー病の診断方法 |
| DE10059418A1 (de) | 2000-11-30 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10060807A1 (de) * | 2000-12-07 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10110747A1 (de) * | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung |
| DE10115945A1 (de) | 2001-03-30 | 2002-10-02 | Bayer Ag | Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung |
| US20050075359A1 (en) * | 2003-03-14 | 2005-04-07 | Rikako Kono | Large conductance calcium-activated K channel opener |
| EP1858853A2 (en) * | 2005-02-24 | 2007-11-28 | Janssen Pharmaceutica N.V. | Novel pyridine derivatives as potassium ion channel openers |
| DE102006042143A1 (de) * | 2006-09-08 | 2008-03-27 | Bayer Healthcare Aktiengesellschaft | Neue substituierte Bipyridin-Derivate und ihre Verwendung |
| DE102006056739A1 (de) * | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung |
| DE102006056740A1 (de) * | 2006-12-01 | 2008-06-05 | Bayer Healthcare Ag | Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung |
| DE102007035367A1 (de) | 2007-07-27 | 2009-01-29 | Bayer Healthcare Ag | Substituierte Aryloxazole und ihre Verwendung |
| DE102007036076A1 (de) | 2007-08-01 | 2009-02-05 | Bayer Healthcare Aktiengesellschaft | Dipeptoid-Produgs und ihre Verwendung |
| DE102007061763A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
| DE102007061764A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Anellierte Cyanopyridine und ihre Verwendung |
| DE102008013587A1 (de) * | 2008-03-11 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung |
| US8791146B2 (en) * | 2008-05-29 | 2014-07-29 | Bayer Intellectual Property Gmbh | 2-alkoxy-substituted dicyanopyridines and their use |
| DE102008062567A1 (de) | 2008-12-16 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Dipeptoid-Prodrugs und ihre Verwendung |
| DE102009006602A1 (de) * | 2009-01-29 | 2010-08-05 | Bayer Schering Pharma Aktiengesellschaft | Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs |
| DE102010030688A1 (de) | 2010-06-30 | 2012-01-05 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Dicyanopyridine und ihre Verwendung |
| US20120058983A1 (en) | 2010-09-02 | 2012-03-08 | Bayer Pharma Aktiengesellschaft | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
| EP2616441B1 (en) * | 2010-09-17 | 2019-08-07 | Purdue Pharma L.P. | Pyridine compounds and the uses thereof |
-
1994
- 1994-08-29 DE DE4430638A patent/DE4430638A1/de not_active Withdrawn
-
1995
- 1995-07-20 TW TW084107499A patent/TW419464B/zh active
- 1995-08-16 EP EP95112833A patent/EP0705820A1/de not_active Withdrawn
- 1995-08-22 US US08/517,873 patent/US5670525A/en not_active Expired - Fee Related
- 1995-08-23 PL PL95310145A patent/PL310145A1/xx unknown
- 1995-08-23 AU AU30205/95A patent/AU697552B2/en not_active Ceased
- 1995-08-24 JP JP7237915A patent/JPH0867670A/ja active Pending
- 1995-08-25 FI FI954007A patent/FI954007A/fi unknown
- 1995-08-25 NZ NZ272851A patent/NZ272851A/en unknown
- 1995-08-25 CN CN95116625A patent/CN1127114A/zh active Pending
- 1995-08-25 IL IL11507295A patent/IL115072A/xx not_active IP Right Cessation
- 1995-08-25 CA CA002156961A patent/CA2156961A1/en not_active Abandoned
- 1995-08-28 HU HU9502520A patent/HUT74618A/hu unknown
- 1995-08-28 NO NO953367A patent/NO308287B1/no not_active IP Right Cessation
- 1995-08-28 KR KR1019950026840A patent/KR960007565A/ko not_active Application Discontinuation
- 1995-08-28 EE EE9500059A patent/EE9500059A/et unknown
- 1995-08-28 ZA ZA957187A patent/ZA957187B/xx unknown
- 1995-08-28 RU RU95114449/04A patent/RU2154635C2/ru active
- 1995-08-28 SK SK1065-95A patent/SK106595A3/sk unknown
- 1995-08-28 CZ CZ952198A patent/CZ219895A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2154635C2 (ru) | 2000-08-20 |
| AU3020595A (en) | 1996-03-14 |
| NO953367L (no) | 1996-03-01 |
| PL310145A1 (en) | 1996-03-04 |
| EP0705820A1 (de) | 1996-04-10 |
| HU9502520D0 (en) | 1995-10-30 |
| IL115072A (en) | 1999-12-31 |
| JPH0867670A (ja) | 1996-03-12 |
| KR960007565A (ko) | 1996-03-22 |
| NZ272851A (en) | 1997-07-27 |
| FI954007A0 (fi) | 1995-08-25 |
| NO953367D0 (no) | 1995-08-28 |
| IL115072A0 (en) | 1995-12-08 |
| US5670525A (en) | 1997-09-23 |
| HUT74618A (en) | 1997-01-28 |
| ZA957187B (en) | 1996-04-17 |
| TW419464B (en) | 2001-01-21 |
| SK106595A3 (en) | 1997-01-08 |
| CZ219895A3 (en) | 1996-03-13 |
| AU697552B2 (en) | 1998-10-08 |
| CN1127114A (zh) | 1996-07-24 |
| DE4430638A1 (de) | 1996-03-07 |
| FI954007A (fi) | 1996-03-01 |
| CA2156961A1 (en) | 1996-03-01 |
| NO308287B1 (no) | 2000-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9510256A (pt) | Derivados de ácido 3-aril-tetrônico | |
| EE9500059A (et) | Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena | |
| FI950910A0 (fi) | Rasvahappojohdannaiset | |
| ATE211131T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
| FI942076A (fi) | Sappihappojohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkaaineina | |
| EE03426B1 (et) | Risperidooni vesilahuselised ravimvormid | |
| FI944800A (fi) | Indoli-2-karboksyylihappojohdannaisia | |
| DE59010756D1 (de) | Silylierte Benzoesäurederivate | |
| FI98067B (fi) | Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi | |
| FI964193A (fi) | Puriinien valmistaminen | |
| NO20003105L (no) | Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike | |
| FI951388A (fi) | Substituoidut heterosykliset karboksyylihappoamidiesterit, niiden valmistus ja niiden käyttö lääkeaineina | |
| IT1273471B (it) | Derivati dell'acido kojico | |
| DK0587264T3 (da) | Vandige farmaceutiske formuleringer indeholdende natriumcromoglycat | |
| NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| DE69514306D1 (de) | Kurzkettige 2-hydroxycarbonsäurederivate von ceramiden | |
| DE69527684D1 (de) | Herstellung von 3-oxy-5-oxo-6-Heptensäurederivaten | |
| KR950702115A (ko) | 디히드로피리딘 유도체의 신규 의약 용도(novel medicinal use of dihydropyridine derivative) | |
| DE69305250D1 (de) | Herstellung von Alkandicarbonsäurederivaten | |
| DE69502982D1 (de) | Herstellung geschützter Aminothiazolylessigsäurederivate | |
| NO20012540D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| FI971964A (fi) | Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi | |
| NO991098D0 (no) | FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater | |
| FI951385A0 (fi) | Substituoidut heterosykliset karboksyylihappoamidit, niiden valmistus ja niiden käyttö lääkeaineina | |
| SE9202013D0 (sv) | Saett foer beredning av loesning foer medicinsk anvaendning |